The administration of the Zoetis vaccine for the treatment of pain in cats with osteoarthritis, a common but difficult-to-diagnose condition that affects the joints in older cats, was approved today, Thursday, by the American Drug Administration (FDA).
The permit of the regulatory authority concerns the administration of this preparation once a month.
The drug, Solensia, with the active substance frunevetmab, is the first veterinary monoclonal antibody approved by the FDA, according to Reuters.
The monoclonal antibodies are made on the basis of antibody copies created by the body to fight an infection, transmits the RES EIA.
What is osteoarthritis?
THE osteoarthritis breaks down the protective cartilage that protects the joints, leading to increased friction causing pain and reduced movement.
Solensia was approved based two studies used cat evaluations by veterinarians and ratings by owners for pet movements before and after treatment.
The most common unwanted actions observed in cats treated with Solensia included vomiting, diarrhea, injection site pain, and itchy skin.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
.jpeg "Nature holidays: on a sailing boat to the Pontine Islands with WWF experts")
.jpg "Megan Fox and “compartmentalization”, the self-defense mechanism that was triggered after suffering violence")
